openPR Logo
Press release

Gastrointestinal Anastomosis Market Set to Witness Significant Growth by 2025-2034

08-26-2025 01:27 PM CET | Health & Medicine

Press release from: Exactitude Consultancy

Gastrointestinal Anastomosis Market

Gastrointestinal Anastomosis Market

Introduction
Gastrointestinal (GI) anastomosis is a critical surgical procedure involving the connection of two segments of the digestive tract, performed after resections for conditions such as cancer, bowel obstruction, Crohn's disease, ulcerative colitis, and trauma. The procedure can be performed using surgical staplers, sutures, or advanced minimally invasive devices. With gastrointestinal cancers, inflammatory bowel disease (IBD), and obesity on the rise globally, the demand for GI anastomosis procedures is expanding rapidly.

Advancements in minimally invasive techniques, increased adoption of surgical staplers, and growing investments in healthcare infrastructure are shaping the gastrointestinal anastomosis market. The next decade promises robust growth, supported by both rising surgical volumes and continuous innovation in surgical devices.

Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/71164

Market Overview
• Market Size (2024): Approximately USD 3.6 billion
• Forecast (2034): Approximately USD 7.1 billion
• CAGR (2025-2034): 7.0%

Growth Drivers:
• Rising prevalence of gastrointestinal cancers and IBD.
• Increasing bariatric surgeries due to the obesity epidemic.
• Technological advancements in surgical staplers and robotic-assisted systems.
• Expansion of healthcare infrastructure in emerging economies.
• Growing preference for minimally invasive surgeries that reduce hospital stays.

Challenges:
• High cost of advanced surgical devices.
• Post-surgical complications such as leaks and infections.
• Limited access to advanced surgical technologies in low-income regions.

Segmentation Analysis
The gastrointestinal anastomosis market can be segmented as follows:
• By Product Type:
o Surgical Staplers (manual, powered)
o Sutures
o Surgical Sealants and Adhesives
o Other Advanced Devices (robotic-assisted tools)

• By Surgery Type:
o Gastrointestinal Surgery (stomach, intestines)
o Colorectal Surgery
o Bariatric Surgery
o Other GI Procedures (trauma, rare conditions)

• By Technique:
o Handsewn Anastomosis
o Mechanical Anastomosis (staplers, devices)
o Hybrid/Robotic-assisted Anastomosis

• By End Use:
o Hospitals (majority share due to surgical infrastructure)
o Ambulatory Surgical Centers (ASCs)
o Specialty Clinics
o Research and Academic Institutes

Summary: Surgical staplers dominate the product segment, owing to their efficiency, precision, and reduced surgical time. Powered staplers are gaining popularity due to consistent performance. Bariatric surgery and colorectal procedures represent major growth areas, particularly with rising obesity and colorectal cancer rates globally.

Explore Full Report here:
https://exactitudeconsultancy.com/reports/71164/gastrointestinal-anastomosis-market

Regional Analysis
• North America:
The largest market, driven by advanced healthcare infrastructure, high prevalence of obesity and colorectal cancer, and early adoption of robotic-assisted surgical systems. The U.S. leads with widespread use of surgical staplers and minimally invasive procedures.
• Europe:
A strong market, with Germany, the UK, France, and Italy as leading contributors. Europe is notable for its focus on patient safety, regulatory oversight, and widespread use of powered staplers in GI surgeries.
• Asia-Pacific:
Expected to record the fastest CAGR, fueled by growing surgical volumes in India and China, rising obesity rates, and increasing incidence of colorectal and gastric cancers. Japan and South Korea are early adopters of robotic-assisted procedures.
• Middle East & Africa:
A developing market where growing healthcare investment and medical tourism are contributing to gradual expansion. Limited access to advanced devices remains a constraint.
• Latin America:
Brazil, Mexico, and Argentina are leading markets, supported by expanding healthcare reforms and rising adoption of laparoscopic surgeries.

Regional Summary: While North America and Europe dominate current revenues, Asia-Pacific is the growth engine for the future, driven by its large population base, rising GI disease burden, and expanding hospital infrastructure.

Market Dynamics
Key Growth Drivers:
• Increasing incidence of colorectal cancer and IBD worldwide.
• Growth in bariatric surgeries due to obesity epidemic.
• Rising preference for minimally invasive and laparoscopic GI surgeries.
• Technological advancements in surgical staplers and sealants.

Key Challenges:
• Post-surgical complications such as anastomotic leaks.
• High costs of advanced stapling and robotic systems.
• Lack of trained surgeons in developing economies.

Latest Trends:
• Development of powered staplers offering consistency and precision.
• Integration of robotic-assisted systems for enhanced surgical outcomes.
• Expansion of bio-absorbable sealants and adhesives to reduce leakage risks.
• Adoption of AI-assisted surgical planning and training platforms.
• Growing medical tourism in Asia and Latin America for cost-effective GI surgeries.

Get Your Exclusive Offer with up to 10% Discount :
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=71164

Competitor Analysis
Key Players:
• Medtronic plc
• Ethicon (Johnson & Johnson)
• B. Braun Melsungen AG
• Conmed Corporation
• Intuitive Surgical Inc.
• Olympus Corporation
• Smith & Nephew plc
• Boston Scientific Corporation
• 3M Company (surgical adhesives)
• Cook Medical

Competitive Landscape:
The market is moderately consolidated, with Medtronic and Ethicon dominating the surgical stapler segment. Intuitive Surgical is a leader in robotic-assisted procedures, while B. Braun and Conmed offer strong portfolios of sutures and surgical tools. Smaller companies are entering with innovations in bio-absorbable sealants and adhesives. Strategic acquisitions, partnerships, and product launches are common strategies shaping the competitive environment.

Conclusion
The Gastrointestinal Anastomosis Market is set for steady growth, fueled by rising GI disorders, expanding bariatric surgeries, and continuous innovation in surgical technologies. From USD 3.6 billion in 2024, the market is projected to nearly double to USD 7.1 billion by 2034, expanding at a CAGR of 7.0%.

Key opportunities include:
• Expanding adoption of powered staplers and robotic-assisted procedures.
• Developing bio-absorbable adhesives and sealants to minimize complications.
• Enhancing surgeon training in emerging economies.
• Leveraging AI and digital technologies for surgical planning and outcomes.

This report is also available in the following languages : Japanese (消化管吻合市場), Korean (위장관 문합술 시장), Chinese (胃肠吻合术市场), French (Marché de l'anastomose gastro-intestinale), German (Markt für gastrointestinale Anastomose), and Italian (Mercato delle anastomosi gastrointestinali), etc.

Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/71164

Our More Reports:

Phototherapies for Psoriasis Market
https://exactitudeconsultancy.com/reports/71430/phototherapies-for-psoriasis-market

Pruritis Market
https://exactitudeconsultancy.com/reports/71432/pruritis-market

Psoriasis Vulgaris Market
https://exactitudeconsultancy.com/reports/71434/psoriasis-vulgaris-market

About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.

https://bulletin.exactitudeconsultancy.com/

https://www.thehealthanalytics.com/

https://www.analytica.global/

https://www.marketintelligencedata.com/

https://www.marketinsightsreports.com/

https://exactitudeconsultancy.com/

Connect Us:
IRFAN TAMBOLI
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Gastrointestinal Anastomosis Market Set to Witness Significant Growth by 2025-2034 here

News-ID: 4160087 • Views:

More Releases from Exactitude Consultancy

Asthma and COPD Drugs Market to Surpass USD 87.6 Billion by 2034
Asthma and COPD Drugs Market to Surpass USD 87.6 Billion by 2034
Pune, India, November 2025 - The latest report from Exactitude Consultancy reveals that the Global Asthma and Chronic Obstructive Pulmonary Disease (COPD) Drugs Market is valued at USD 59.4 billion in 2024 and is expected to reach USD 87.6 billion by 2034, growing at a CAGR of 3.9% during 2025-2034. Growth is driven by increasing respiratory disease prevalence, innovation in inhalation devices, and the rise of biologic therapies targeting severe
Healthcare Finance Solutions Market to Surpass USD 240 Billion by 2034
Healthcare Finance Solutions Market to Surpass USD 240 Billion by 2034
Pune, India, November 2025 - According to the latest report by Exactitude Consultancy, the global Healthcare Finance Solutions Market is expected to grow from approximately USD 143 billion in 2024 to around USD 240 billion by 2034, registering a CAGR of 5.3% during 2025-2034. This growth is driven by the expansion of healthcare infrastructure, digital transformation initiatives, and rising capital expenditure across hospitals, diagnostics, and pharmaceutical sectors. Download Full PDF Sample
Wearable Ambulatory Monitoring Devices Market to Reach USD 23.4
Wearable Ambulatory Monitoring Devices Market to Reach USD 23.4
Next-Generation Biosensors, Cloud Analytics, and Telehealth Expansion Accelerate Adoption Across Cardiovascular and Chronic Care Applications Pune, India, November 2025 - According to a recent report by Exactitude Consultancy, the Global Wearable Ambulatory Monitoring Devices Market is valued at USD 12.8 billion in 2024 and is projected to reach USD 23.4 billion by 2034, growing at a CAGR of 6.3% during 2025-2034. The surge in telemedicine usage, expansion of chronic disease management
Glioblastoma Multiforme Market Projected to Reach USD 5.8 Billion by 2034
Glioblastoma Multiforme Market Projected to Reach USD 5.8 Billion by 2034
The global market for Glioblastoma Multiforme (GBM) is expected to expand significantly over the 2024-2034 period. With a base year value of around US $3.5 billion in 2024, the market is projected to reach about US $5.8 billion by 2034 - implying a compound annual growth rate (CAGR) of approximately 5.2% from 2025 through 2034. The study covers key treatment modalities, regional dynamics, segment-level detail, competitive landscape, and growth enablers

All 5 Releases


More Releases for Anastomosis

Surge In Surgical Procedures Drives Anastomosis Device Market Growth: The Drivin …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Anastomosis Devices Market Size Growth Forecast: What to Expect by 2025? In recent times, there has been robust growth in the size of the anastomosis devices market. The market, which stood at $3.66 billion in 2024, is projected to expand to $3.9 billion in 2025, representing a compound annual
Top Factor Driving Anastomosis Devices Market Growth in 2025: Surge In Surgical …
Which drivers are expected to have the greatest impact on the over the anastomosis devices market's growth? An upward trajectory in surgical operations is predicted to accelerate the expansion of the anastomosis device market. The term, surgical operations, is applied to any medical procedure that necessitates cutting into a patient's body. Anastomosis devices, principally utilized in surgical operations, allow the connection of two parts of the body, like blood vessels or
Anastomosis Device Market worth $4.4 billion by 2027
Browse 289 market data Tables and 42 Figures spread through 305 Pages and in-depth TOC on "Anastomosis Device Market by Product, Surgical Staplers (Manual, Powered), Surgical Sutures (Absorbable, Non-absorbable, Automated), and Surgical Sealants and Adhesives, Application (CVDs, GI Surgeries) and End Users - Global Forecast to 2027 Anastomosis Device Market [https://www.marketsandmarkets.com/Market-Reports/anastomosis-device-market-5343963.html?utm_source=abnewswire.com&utm_medium=referral&utm_campaign=anastomosisdevicemarket] is projected to grow from USD 3.0 billion in 2022 to USD 4.4 billion by 2027, at a CAGR of
Anastomosis Devices Market
Market Overview: The Global Anastomosis Devices Market achieved a valuation of US$ YY million in 2022 and is poised to reach US$ YY million by 2030, exhibiting a robust CAGR of YY% during the forecast period from 2023 to 2030. Anastomosis devices play a critical role in surgical procedures, facilitating the connection of blood arteries, intestines, or other tubular bodily parts. These anastomoses are essential for healing damaged tissues, restoring blood flow,
Anastomosis Device Market Trends, Growth, Size, Analysis, Outlook by 2028
An exceptional companion Anastomosis Device Market report takes into consideration diverse segments of the market analysis that today's business ask for. The report provides estimations of CAGR values, market drivers and market restraints about the Veterinary Diagnostics industry which are helpful for the businesses in deciding upon numerous strategies. The base year for calculation in the report is taken as 2022 whereas the historic year is 2019 which will tell
Anastomosis Device Market Report Up to 2031
Visiongain has published a new report on Anastomosis Device Market Report to 2031: Forecasts by Type (Surgical Staplers (Manual and Powered), Surgical Sutures (Absorbable Sutures (Synthetic Sutures (Polyglactin 910 Sutures, Poliglecaprone 25 Sutures, Polydioxanone Sutures, Polyglycolic Acid Sutures, and Other Synthetic Sutures), and Natural Sutures), Non-absorbable Sutures (Polypropylene, Nylon, Stainless Steel, and Other Non-absorbable Sutures), Automated Suturing Devices (Disposable and Reusable), Surgical Sealants and Adhesives (Natural/Biological (Fibrin-based, Collagen-based, and Albumin-based)